About Richard Lee, MD, PhD
Video: Meet Dr. Lee and learn about bladder cancer
After completing a bachelor's and a master's degree at Harvard, Dr. Lee then completed his medical school (M.D.) and graduate school (Ph.D.) training at the Albert Einstein College of Medicine, in the Bronx, New York. He came to MGH for internal medicine residency training and then completed medical oncology fellowship training through the Dana-Farber Cancer Institute / MGH joint program. During that time, he performed basic science research at the Whitehead Institute of MIT.
Departments, Centers, & Programs:
Clinical Interests:
- Bladder cancer
- Prostate cancer
- Renal Cancer
- Testicular, penile and genito-urinary cancers
- Translational research
Treats:
- Adult
Locations
Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4000
Fax: 617-726-8685
Mass General Cancer Center in Waltham
52 Second Ave.
Suite 1110
Waltham, MA 02451
Phone: 781-487-6100
Medical Education
- MD, Albert Einstein college of medicine
- PhD, Albert Einstein college of medicine
- Residency, Massachusetts General Hospital
- Fellowship, Dana Farber Cancer Institute
American Board Certifications
- Medical Oncology, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Since joining the staff at MGH, Dr. Lee has been engaged in translational studies of circulating tumor cells (CTCs) from peripheral blood, using a new technology developed at MGH. Our hope is that this "CTC-Chip" may have clinical usefulness for cancer patients. In addition to seeing patients, Dr. Lee is also interested in clinical trials of new drugs to treat genitourinary cancers.